New Zealand markets open in 2 hours 8 minutes

BIIB Apr 2024 140.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.30000.0000 (0.00%)
As of 02:30PM EST. Market open.
Full screen
Previous close0.3000
Open0.3000
Bid0.0000
Ask0.0000
Strike140.00
Expiry date2024-04-19
Day's range0.3000 - 0.3000
Contract rangeN/A
Volume1
Open interestN/A
  • Insider Monkey

    14 Best Beaten Down Stocks To Buy Right Now

    In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now. The stock market of […]

  • Investor's Business Daily

    Is Eli Lilly Stock A Buy As Amgen Enters The Red-Hot Weight-Loss Ring?

    There's a growing field of competitors in the weight-loss drugs space, where Lilly and Novo currently dominate. Is Eli Lilly stock a buy?

  • GlobeNewswire

    Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

    SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development of new medicines for ALS, with the potential to accelerate further discovery in the field CAMBRIDGE, Mass., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opin